Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

USFDA approves Bristol Myers Squibb Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid Tumors

Ruchika Sharma15 Jun 2024 4:26 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Suven Pharma to buy 67.5 percent stake in Sapala Organics for Rs 229.5 crore

Ruchika Sharma15 Jun 2024 2:56 PM IST

Mumbai: Suven Pharmaceuticals has announced that the Company will acquire 67.5 per cent stake in Sapala Organics Private Limited for Rs 229.5...

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Sun Pharma, Moebius Medical present positive data from phase 2b trial of MM-II in painful knee osteoarthritis patients at EULAR 2024

Ruchika Sharma15 Jun 2024 12:30 PM IST

Sun Pharma and Moebius Medical, who have been jointly developing MM-II, have announced plans to initiate a Phase 3 clinical program.

KMV Narayana Rao appointed as Vice President - ARD at NATCO Research Centre

Ruchika Sharma15 Jun 2024 11:56 AM IST

Hyderabad: Through a recent BSE filing, Natco Pharma has informed that K.M.V. Narayana Rao has been appointed as Vice President - ARD at NATCO...

Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indication

Bayer gets Breakthrough Therapy designation in China for lung cancer drug BAY 2927088

Ruchika Sharma15 Jun 2024 10:00 AM IST

Berlin: Bayer has announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has...

Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal

Pfizer Duchenne gene therapy fails to meet primary end point in Phase 3 CIFFREO trial

Ruchika Sharma14 Jun 2024 5:23 PM IST

New York: Pfizer Inc. has announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating...

Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority Nod

Zydus Lifesciences bags USFDA tentative nod for Azilsartan Medoxomil and Chlorthalidone Tablets for hypertension

Ruchika Sharma14 Jun 2024 4:02 PM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received tentative approval from the United States Food and Drug...

Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal

Lupin Nagpur Injectable facility concludes USFDA inspection with zero 483 observations

Ruchika Sharma14 Jun 2024 12:33 PM IST

Mumbai: Global pharma major Lupin Limited today announced that the United States Food and Drug Administration (U.S. FDA) has completed an...

USFDA Approves Bionpharmas Generic HIV Drug Etravirine

AstraZeneca Farxiga gets USFDA nod for paediatric type 2 diabetes

Ruchika Sharma14 Jun 2024 11:30 AM IST

Cambridge: AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) for the improvement of...

Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosis

Dr Reddy's Labs to commercialize Ingenus Pharma cancer injection Cyclophosphamide in US

Ruchika Sharma13 Jun 2024 4:40 PM IST

Hyderabad: Dr Reddy's Laboratories, Inc., a step down wholly owned subsidiary of the Company (referred to hereinafter as "Dr. Reddy's USA"), and...

Biocon appoints Mukesh Kamath as Interim CFO, Key Managerial Personnel

Ruchika Sharma13 Jun 2024 4:09 PM IST

Bangalore: Biocon has announced the appointment of Mukesh Kamath, Head - Business Finance R&D, as the Interim Chief Financial Officer and Key...

Granules India packaging facility in US successfully completes USFDA inspection

Torrent Pharma gets 5 USFDA observations for Indrad facility

Ruchika Sharma13 Jun 2024 12:09 PM IST

Ahmedabad: Through a recent BSE filing, Torrent Pharma has informed that the US Food and Drug Administration (USFDA) has issued Form 483...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok